CA2123647C

Bioabsorbable copolymer and coating composition containing same

Abstract

A bioabsorbable copolymer is obtained from the polymerization of a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of a polyhydric alcohol initiator. The copolymer is useful, inter alia, as a coating for a surgical suture.

CA2123647C, drawing sheet 1
Sheet 1 of 1

Term

Term ended

Expired 16 May 2014, 12.4 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

32 claims: 24 independent, 8 dependent

  1. 1
    CA 02123647 2003-12-12 THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:1. A bioabsorbable coploymer obtained by polymerizing a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric alcohol as initiator, the initiator having at least 3 hydroxy groups.
  2. 2
    The copolymer of Claim 1 wherein the other copolymerizable monomer is selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate .
  3. 3
    The copolymer of Claim 1 or 2 wherein the polyhydric alcohol initiator is selected from the group consisting of glycerol, trimethylolpropane, 1,2,4-butanetriol, 1,2,6hexanetriol, triethanolamine, triisopropanolamine, erythritol, threitol, pentaerythritol, ribitol, arabinitol, xylitol, N,N,Ν' , Ν'-tetrakis (2-hydroxy-ethyl) ethylenediamine, N,N,Ν' , Ν'-tetrakis (2-hydroxypropyl) ethylenediamine, dipentaerythritol, allitol, dulcitol, glucitol, altritol, iditol, sorbitol, mannitol and insitol.
  4. 4
    The copolymer of any one of Claims 1 to 3, containing from about 70 to about 98 weight percent epsilon-caprolactonederived units, the balance of the copolymer being derived from the other copolymerizable monomer(s).
  5. 5
    The copolymer of any one of Claims 1 to 4, possessing an inherent viscosity of from about 0.10 to about 0.60 dl/g CA 02123647 2003-12-12 when measured in chloroform at a concentration of 0.2500 g/dl at 30°C.
  6. 6
    The copolymer of any one of Claims 1 to 5, wherein the polyhydric alcohol is employed in an amount of from about 0.5 to about 5 weight percent of the total monomer mixture.
  7. 7
    A medical device fabricated in whole or in part from a bioabsorbable copolymer obtained by polymerizing a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric alcohol as initiator, the initiator having at least 3 hydroxy groups.
  8. 8
    The medical device of Claim 7 wherein the other copolymerizable monomer is selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate.
  9. 9
    The medical device of Claim 7 or 8 wherein the polyhdric alcohol initiator is selected from the group consisting of glycerol, trimethylolpropane, 1,2,4-butanetriol, 1,2,6hexanetriol, triethanolamine, triisopropanolamine, erythritol, threitol, pentaerythritol, ribitol, arabinitol, xylitol, N,N,Ν' , Ν'-tetrakis (2-hydroxy-ethyl) ethylenediamine, N,N,Ν' ,Ν'-tetrakis (2-hudroxypropyl) ethylenediamine, dipentaerythritol, allitol, dulcitol, glucitol, altritol, iditol, sorbitol, mannitol and inositol.
  10. 10
    The medical device of any one of Claims 7 to 9, wherein CA 02123647 2005-12-12 the copolymer contains from about 70 to about 98 weight percent epsilon-caprolactone-derived units, the balance of the copolymer being derived from the other copolymerizable monomer (s).
  11. 11
    The medical device of any one of Claims 7 to 10, wherein the copolymer possesses an inherent viscosity from about 0.10 to about 0.60 dl/g when measured in chloroform at a concentration of 0.2500 g/dl at 30°C.
  12. 12
    The medical device of any one of Claims 7 to 11, wherein the polyhydric alcohol initiator is employed in an amount of from about 0.5 to about 5 weight percent of the total monomer mixture.
  13. 13
    The medical device of any one of Claims 7 to 12, wherein the medical device is a surgical suture coated with a composition comprising a bioabsorbable copolymer obtained by polymerizing a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of a polyhydric alcohol as initiator.
  14. 14
    Use of the composition of any one of Claims 1, 2, 3, 4, 5, or 6 for a medical device.
  15. 15
    Use of the composition of any one of Claims 1, 2, 3, 4, 5 or 6 for a medical device wherein the medical device is a suture coated with a copolymer.
  16. 16
    A bioabsorable epsilon-caprolactone copolymer characterized in that it has a branched or star CA 02123647 2005-12-12 configuration, and obtained using, during polymerization, an initiator comprising a polyhydric alcohol having at least three hydroxy groups.
  17. 17
    A branched or star configuration copolymer obtained using an initiator comprising a polyhydric alcohol having at least three hydroxy groups during polymerization characterized in that it comprises a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer and that it is bioabsorbable.
  18. 18
    Use of a bioabsorbable polymer as claimed in any one of Claim 1 to 6 as a coating for a medical clip or staple.
  19. 19
    Use of a copolymer as claimed in Claim 16 or 17 as a coating for a surgical suture.
  20. 20
    A process of making a bioabsorbable surgical element fabricated in whole or in part from a bioabsorbable polymer said process comprising:polymerizing a major amount of epsilon-caprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric alcohol as initiator, the initiator having at least 3 hydroxy groups .
  21. 21
    A surgical suture coated with a coating composition comprising a branched or star shaped bioabsorbable copolymer obtained by polymerizing a major amount of ecaprolactone and a minor amount of at least one other copolymerizable monomer in the presence of polyhydric CA 02123647 2005-12-12 alcohol having 3 or more hydroxy groups as initiator, said suture exhibiting a mean force for achieving knot run down which is less than that exhibited by a suture coated with a coating composition which is obtained in the same manner but with a dihydric alcohol as initiator.
  22. 22
    The surgical suture of Claim 21 which is a bioabsorbable braided suture.
  23. 23
    The suture of Claim 21 or 22 wherein the other copolymerizable monomer is selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate.
  24. 24
    The suture of any one of Claims 21 to 23 wherein the polyhydric alcohol initiator is selected from the group consisting of glycerol, trimethylolpropane, 1, 2, 4butanetriol, 1, 2, 6-hexanetriol, triethanolamine, triisopropanolamine, erythritol, threitol, pentaerythritol, ribitol, arabinitol, xylitol, Ν,Ν,Ν',Ν'tetrakis (2-hydroxyethyl) ethylenediamine, Ν,Ν,Ν',Ν'tetrakis (2-hydroxypropyl) ethylenediamine, dipentaerythritol, allitol, dulcitol, glucitol, altritol, iditol, sorbitol, mannitol and inositol.
  25. 25
    The suture of any one of Claims 21 to 24 wherein the copolymer contains from about 70 to about 98 weight percent ε-caprolactone-derived units, the balance of the copolymer being derived from the other copolymerizable monomer (s).
  26. 26
    The suture of any one of Claims 21 to 24, wherein the CA 02123647 2005-12-12 copolymer contains from about 80 to 95 weight percent εcaprolactone-derived units, the balance of the copolymer being derived from the other copolymerizable monomer (s).
  27. 27
    The suture of any one of Claims 21 to 26 wherein the copolymer possesses an inherent viscosity from about 0.10 to about 0.60 dl/g when measured in chloroform at a concentration of 0.2500 g/dl at 30°C.
  28. 28
    The suture of any one of Claims 21 to 26, wherein the copolymer possesses an inherent viscosity from about 0.20 to about 0.50 dl/g when measured in chloroform at a concentration of 0.2500 g/dl at 30°C.
  29. 29
    The suture of any one of Claims 21 to 28, wherein the polyhydric alcohol initiator is employed in an amount of from about 0.5 to about 5 weight percent of the total monomer mixture.
  30. 30
    The suture of any one of Claims 21 to 28 wherein the polyhydric alcohol initiator is employed in an amount of from about 0.1 to about 2 weight percent of the total monomer mixture.
  31. 31
    The suture of any one of Claims 21 to 30, wherein the coating composition is applied to a suture at a level of from about 0.2 to about 4 weight percent of the entire coated suture.
  32. 32
    The suture of any one of Claims 21 to 30, wherein the coating composition is applied to a suture at a level of from about 0.5 to about 3 weight percent of the entire coated suture.
Independent claims32